Scarica l'app Stockscreener
22.65
0.22%
-0.05
Precedente Chiudi:
$22.70
Aprire:
$22.37
Volume 24 ore:
816.06K
Relative Volume:
1.06
Capitalizzazione di mercato:
$2.83B
Reddito:
$1.80B
Utile/perdita netta:
$15.62M
Rapporto P/E:
188.75
EPS:
0.12
Flusso di cassa netto:
$118.36M
1 W Prestazione:
-2.33%
1M Prestazione:
-6.79%
6M Prestazione:
+8.06%
1 anno Prestazione:
+27.25%
Intervallo 1D:
$22.22
$22.93
Intervallo di 1 settimana:
$22.01
$23.43
Portata 52W:
$16.37
$26.09
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Confronta PRVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
22.65 | 2.83B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
282.55 | 46.63B | 2.86B | 780.66M | 1.20B | 4.72 |
|
DOCS
Doximity Inc
|
55.92 | 11.05B | 550.17M | 201.35M | 232.07M | 1.00 |
|
TEM
Tempus Ai Inc
|
71.28 | 10.75B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
104.76 | 9.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.93 | 7.12B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com Australia
Privia Health’s SWOT analysis: capital-efficient model drives stock growth By Investing.com - Investing.com Canada
Rhumbline Advisers Increases Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Barclays Raises Privia Health (PRVA) PT to $24 on Strong Q1 Fee-for-Service Performance - MSN
California State Teachers Retirement System Sells 879 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Buy” by Analysts - Defense World
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution - MSN
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution Offset Revenue Miss - FinancialContent
How To Trade (PRVA) - news.stocktradersdaily.com
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 to Think Twice About - Yahoo Finance
Two Sigma Advisers LP Buys Shares of 48,100 Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $32.00 at JPMorgan Chase & Co. - Defense World
Ziegler Advises Integrated Medical Services On Partnership with Privia Health Group - Yahoo Finance
PRVA Stock Target Raised by JP Morgan Analyst | PRVA Stock News - GuruFocus
JPMorgan Increases Price Target for Privia Health (PRVA) to $32 - GuruFocus
JPMorgan Increases Price Target for Privia Health (PRVA) to $32 | PRVA Stock News - GuruFocus
Privia Health Group (NASDAQ:PRVA) Given New $24.00 Price Target at Barclays - Defense World
11 Analysts Have This To Say About Privia Health Gr - Benzinga
Privia Health Gr (PRVA) Sees Price Target Boost by Barclays | PRVA Stock News - GuruFocus
Barclays Adjusts Privia Health (PRVA) Price Target Post Q1 | PRV - GuruFocus
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Ameriprise Financial Inc. - Defense World
(PRVA) Long Term Investment Analysis - news.stocktradersdaily.com
Cetera Investment Advisers Reduces Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group Approves Key Proposals at Meeting - TipRanks
Bank of America Corp DE Has $19.98 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
3 Healthcare Stocks with Mounting Challenges - Yahoo Finance
Investing in Smarter Healthcare: The New Era of AI-Driven Medicine - The Globe and Mail
Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks - Yahoo Finance
Some May Be Optimistic About Privia Health Group's (NASDAQ:PRVA) Earnings - Yahoo Finance
Top Executives Cash In on Privia Health Group Stock - TipRanks
How the (PRVA) price action is used to our Advantage - news.stocktradersdaily.com
The Manufacturers Life Insurance Company Trims Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Privia Health’s Earnings Call Highlights Growth and Challenges - TipRanks
Privia Health Group’s Strong Performance and Strategic Expansion Drive Positive Outlook - TipRanks
Has Privia Health Group, Inc.'s (NASDAQ:PRVA) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st
Tower Research Capital LLC TRC Sells 799 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Truist Securities Adjusts Price Target on Privia Health Group to $30 From $28, Maintains Buy Rating - marketscreener.com
Privia Health Q1 2025 slides: Strong growth and margin expansion fuel raised guidance - Investing.com
Privia Health: Q1 Earnings Snapshot - New Haven Register
Privia Health Group Inc (PRVA) Q1 2025 Earnings Call Highlights: Strong Growth and Strategic ... By GuruFocus - Investing.com Canada
Privia Health Reports Strong Q1 2025 Results - TipRanks
Privia Health Group: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Privia Health Group: Strong Financial Performance and Strategic Growth Positioning Justify Buy Rating - TipRanks
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Privia Health Group Inc Azioni (PRVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Mehrotra Parth | Chief Executive Officer |
May 12 '25 |
Sale |
24.99 |
13,773 |
344,187 |
423,143 |
| Mountcastle David | EVP & Chief Financial Officer |
May 12 '25 |
Sale |
24.99 |
3,322 |
83,017 |
172,909 |
0.49%
0.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):